Does AMBRISENTAN Cause Neoplasm malignant? 264 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 264 reports of Neoplasm malignant have been filed in association with AMBRISENTAN (AMBRISENTAN). This represents 0.3% of all adverse event reports for AMBRISENTAN.
264
Reports of Neoplasm malignant with AMBRISENTAN
0.3%
of all AMBRISENTAN reports
55
Deaths
93
Hospitalizations
How Dangerous Is Neoplasm malignant From AMBRISENTAN?
Of the 264 reports, 55 (20.8%) resulted in death, 93 (35.2%) required hospitalization, and 5 (1.9%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMBRISENTAN. However, 264 reports have been filed with the FAERS database.
What Other Side Effects Does AMBRISENTAN Cause?
Dyspnoea (13,367)
Death (7,497)
Headache (7,325)
Pneumonia (4,693)
Dizziness (4,561)
Fatigue (4,436)
Diarrhoea (4,312)
Nausea (3,986)
Fluid retention (3,927)
Malaise (3,839)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which AMBRISENTAN Alternatives Have Lower Neoplasm malignant Risk?
AMBRISENTAN vs AMBROSIA ARTEMISIIFOLIA POLLEN
AMBRISENTAN vs AMBROXOL
AMBRISENTAN vs AMDINOCILLIN PIVOXIL
AMBRISENTAN vs AMG-510
AMBRISENTAN vs AMIFAMPRIDINE